{"id":824512,"date":"2026-07-10T16:29:02","date_gmt":"2026-07-10T16:29:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=824512"},"modified":"2026-07-10T16:29:02","modified_gmt":"2026-07-10T16:29:02","slug":"tremfya-drug-market-size-to-reach-usd-1018-billion-by-2031-as-expanding-treatment-applications-support-market-growth","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/tremfya-drug-market-size-to-reach-usd-1018-billion-by-2031-as-expanding-treatment-applications-support-market-growth_824512.html","title":{"rendered":"Tremfya Drug Market Size to Reach USD 10.18 Billion by 2031 as Expanding Treatment Applications Support Market Growth"},"content":{"rendered":"
\"Tremfya<\/a><\/div>\n
Mordor Intelligence has published a new report on tremfya drug market, offering a comprehensive analysis of trends, growth drivers, and future projections.<\/div>\n

Tremfya Drug Market Overview<\/p>\n

According to Mordor Intelligence, the tremfya drug market size<\/a> is projected to grow from USD 6.43 billion in 2026 to USD 10.18 billion by 2031, registering a CAGR of 9.61% during the forecast period. The market growth is supported by expanding therapeutic applications, increasing adoption of targeted biologic treatments, and wider use across chronic inflammatory disease management.<\/p>\n

The tremfya drug market continues to expand as healthcare providers increasingly use targeted therapies for conditions such as plaque psoriasis, psoriatic arthritis, ulcerative colitis, and Crohn’s disease. Tremfya’s clinical position is supported by its targeted mechanism focused on IL-23 pathways, helping physicians manage immune-mediated conditions through advanced biologic treatment approaches.<\/p>\n

The expansion of Tremfya beyond dermatology applications into gastroenterology has increased its role across multiple treatment areas. Growing recognition of biologics in chronic disease management and the need for long-term treatment options are supporting the tremfya drug market growth. Increased awareness among patients and healthcare professionals is also influencing adoption across developed and emerging healthcare systems.<\/p>\n

Tremfya Drug Market Trends<\/p>\n

Growing Use Across Multiple Chronic Conditions<\/p>\n

The expansion of Tremfya into additional therapeutic areas is one of the major factors influencing the tremfya drug market trends. Initially associated with dermatology treatments, its use has expanded into inflammatory bowel disease care, supporting wider adoption among specialists.<\/p>\n

Increasing Preference for Targeted Biologic Treatments<\/p>\n

Biologic therapies are becoming an important part of treatment plans for immune-related disorders. Tremfya’s focus on specific immune pathways provides healthcare professionals with another option for managing complex conditions where conventional treatments may not provide desired outcomes.<\/p>\n

Expanding Treatment Delivery Options<\/p>\n

Flexible administration methods are becoming increasingly important in chronic care management. The availability of different treatment delivery approaches supports patient convenience and helps reduce dependence on traditional healthcare settings.<\/p>\n

Growing Focus on Specialty Healthcare Services<\/p>\n

The demand for specialty medicines continues to increase as healthcare providers manage complex inflammatory diseases. Hospitals, specialty clinics, and pharmacies are strengthening their capabilities to support biologic treatment requirements.<\/p>\n

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https:\/\/www.mordorintelligence.com\/ja\/industry-reports\/tremfya-drug-market?utm_source=abnewswire<\/a><\/p>\n

Tremfya Drug Market Segmentation<\/p>\n

By Application<\/p>\n